Grace Therapeutics Inc. (GRCE)
GRCE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.99
-1.49% on the day
Market cap
$41.9M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-03-31
Net income
No annual revenue filed since the period ending 2022-03-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | GRCE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001444192 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2022-03-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-24 |
| Latest annual report | 10-K | 2026-06-18 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEFA14A | 2026-07-28 |
Source: SEC EDGAR submissions feed, 590 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SCYX | SCYNEXIS Inc. | $3.99 | -0.99% | $39.7M |
| DWTX | Dogwood Therapeutics Inc. | $1.30 | -5.11% | $44.2M |
| ANVS | Annovis Bio Inc. | $1.06 | -7.83% | $45.2M |
| EDSA | Edesa Biotech Inc. Common Shares | $2.85 | -3.23% | $38.4M |
| CELU | Celularity Inc. | $1.42 | -3.40% | $46.1M |
| SER | Serina Therapeutics Inc. | $1.82 | -6.19% | $46.2M |
| VERU | Veru Inc. | $2.19 | -8.94% | $37.3M |
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier